PMC:7736111 / 83872-84214 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7736111","sourcedb":"PMC","sourceid":"7736111","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7736111","text":"These studies along with others thus suggest that robust activation followed by the exhaustion of CD4+ and CD8+ T cells may be responsible for the disease progression, while therapies like checkpoint inhibitors (anti-PD-1 antibody; NCT04268537) which may prevent T cell exhaustion and restore their functional state may benefit some patients.","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"2076","span":{"begin":333,"end":341},"obj":"Species"},{"id":"2077","span":{"begin":98,"end":101},"obj":"Gene"},{"id":"2078","span":{"begin":107,"end":110},"obj":"Gene"}],"attributes":[{"id":"A2076","pred":"tao:has_database_id","subj":"2076","obj":"Tax:9606"},{"id":"A2077","pred":"tao:has_database_id","subj":"2077","obj":"Gene:920"},{"id":"A2078","pred":"tao:has_database_id","subj":"2078","obj":"Gene:925"},{"subj":"2076","pred":"source","obj":"LitCovid-PubTator"},{"subj":"2077","pred":"source","obj":"LitCovid-PubTator"},{"subj":"2078","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T494","span":{"begin":0,"end":342},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T494","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#93e6ec","default":true},{"id":"LitCovid-sentences","color":"#ecd793"}]}]}}